Stage IV Ovarian Cancer

Showing 1 - 25 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

Enrolling by invitation
  • Stage III Vulvar Cancer
  • +7 more
  • Intervention group triads
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Aug 10, 2023

Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jul 18, 2023

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,

Recruiting
  • Ovarian Cancer
  • +13 more
  • Mind-body resilience training
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jun 28, 2022

Stage IV Ovarian Cancer, Testis Cancer, Refractory, Endometrial Cancer Recurrent Trial in Guangzhou (Claudin6 targeting CAR-NK

Recruiting
  • Stage IV Ovarian Cancer
  • +3 more
  • Claudin6 targeting CAR-NK cells
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Jun 5, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,

Terminated
  • Stage III Fallopian Tube Cancer
  • +14 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 17, 2021

Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Dallas (Vigil™ Vaccine, Bevacizumab)

Completed
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
  • Dallas, Texas
    Mary Crowley Cancer Research Centers
Oct 15, 2021

Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)

Recruiting
  • Stage II Breast Cancer
  • +22 more
  • Behavioral Intervention
  • Bay City, Michigan
  • +7 more
Sep 29, 2021

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +14 more
  • Diagnostic Microscopy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 5, 2021

Metastatic Ovarian Carcinoma, Peritoneal Carcinomatosis, Stage III Ovarian Cancer Trial in Pierre-Bénite (Combined PIPAC / IV

Recruiting
  • Metastatic Ovarian Carcinoma
  • +6 more
  • Combined PIPAC / IV chemotherapy treatment
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Aug 4, 2021

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (18F-DCFPyL)

Recruiting
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
  • 18F-DCFPyL
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 31, 2021

Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Boston (Culdocentesis, Vaginal Swab, Chromopertubation)

Terminated
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
  • Culdocentesis
  • +4 more
  • Boston, Massachusetts
  • +1 more
May 1, 2020

Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Japan, Korea, Republic of,

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +2 more
  • Phoenix, Arizona
  • +144 more
Aug 6, 2019

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Bevacizumab
  • +5 more
  • Anniston, Alabama
  • +631 more
Jul 19, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Philadelphia (Paclitaxel, Carboplatin,

Completed
  • Primary Peritoneal Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Apr 3, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Trial in

Completed
  • Fallopian Tube Carcinoma
  • +7 more
  • Hamilton, Ontario, Canada
  • +3 more
Jul 20, 2018

Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Dallas (Vigil™ Vaccine, Carboplatinum, Carboplatinum and Taxol)

Completed
  • Stage III Ovarian Cancer
  • Stage IV Ovarian Cancer
  • Vigil™ Vaccine
  • +2 more
  • Dallas, Texas
    Mary Crowley Cancer Research Centers
May 21, 2018

Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer Trial (drug, procedure, other)

Withdrawn
  • Stage IIIA Fallopian Tube Cancer
  • +11 more
  • (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG)
  • +2 more
  • (no location specified)
Jun 4, 2018

Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,

Terminated
  • Nausea and Vomiting
  • +26 more
  • Adjuvant Therapy
  • +7 more
  • Hinsdale, Illinois
  • +1 more
Apr 24, 2018